
Italy · Medical devices startup
DIALYBRID is an Italian medical device company based in Cantù, founded in 2020.
Funding reportedLast round: Seed
Follow DIALYBRID and see its new rounds in your feed.Start following
DIALYBRID is an Italian medical device company based in Cantù, founded in 2020.
The company specializes in developing and commercializing innovative arteriovenous vascular grafts specifically for hemodialysis. DIALYBRID was established through a partnership between LIFTT and Bioengineering Laboratories S.r.l. (BEL). The company's main product is the Silkothane® Arteriovenous Graft (SAG), which is a semi-resorbable vascular prosthesis designed for hemodialysis vascular access. This graft features a unique three-layered structure that aims to enhance both short-term usability and long-term performance. DIALYBRID focuses on research and development, along with the commercialization of advanced vascular access solutions, positioning itself within the healthcare and life sciences sector.
Funding, as reported
From DIALYBRID's own website: 5 on the team.
AdvisersTommaso Proserpio
What they build
Known for
health careelectrospinningmanufacturingnanofibrous meshesmedical equipment manufacturingmedical device innovationbiocompatible materialssag (silkothane arteriovenous graft)hospital & health careadvanced materials researchsilkothane technologyvascular graftssemi-degradable vascular prostheseshealthbiotechnologyearly cannulation grafts
Built with from their website
Google Tag ManagerWordPress.orgFont AwesomeViewport MetaGoogle Font APIMicrosoft ExchangeMySQLMicrosoft 365 Apps & ServicesMobile FriendlySmart Slider 3
SwiperRSSGoogle AnalyticsiubendaGoogle Analytics 4WordpressMicrosoft Exchange OnlineNginx
Add your raise, your deck and your story, and put DIALYBRID in front of investors. Or tell us what we have wrong.